Literature DB >> 11824821

Simultaneous measurement of zolmitriptan and its major metabolites N-desmethylzolmitriptan and zolmitriptan N-oxide in human plasma by high-performance liquid chromatography with coulometric detection.

E M Clement1, M Franklin.   

Abstract

Zolmitriptan, N-desmethylzolmitriptan, zolmitriptan N-oxide and an internal standard (an analogue of zolmitriptan) were extracted from plasma by a solid-phase extraction (SPE). Chromatography was performed using isocratic reversed-phase high-performance liquid chromatography (HPLC) with coulometric end-point detection. The standard curves were linear over the range 2-20 ng/ml for zolmitriptan and its metabolites in plasma. The mean inter- and intra-assay coefficients of variation over the range of the standard curves were less than 11%. The absolute recovery averaged 87, 58 and 77% for zolmitriptan. N-desmethylzolmitriptan and zolmitriptan N-oxide, respectively. The assay sensitivity was 0.5 ng for each analyte.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11824821     DOI: 10.1016/s0378-4347(01)00470-4

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  3 in total

1.  A new stability indicating HPLC method for related substances in zolmitriptan.

Authors:  E K S Vijayakumar; M A Samel; S B Bhalekar; S M Pakhale
Journal:  Indian J Pharm Sci       Date:  2010-01       Impact factor: 0.975

Review 2.  The triptan formulations : how to match patients and products.

Authors:  Alan M Rapoport; Stewart J Tepper; Marcelo E Bigal; Fred D Sheftell
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

3.  Identification of major degradation products of ketoconazole.

Authors:  Rajendra A Mhaske; Shirish Sahasrabudhe
Journal:  Sci Pharm       Date:  2011-10-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.